Glaucoma Clinical Trials

Find Glaucoma Clinical Trials Near You

The Multi-Omics Analysis of Lens Zonule Relaxation in The PACG Pathogenesis

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY

Compared with primary angle-closure glaucoma (PACG) patients without zonular laxity and the control group, there are differentially expressed molecules in PACG patients with zonular laxity, and a potential mechanistic network can be constructed therefrom.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 50
Healthy Volunteers: f
View:

• Clinically diagnosed with primary angle-closure glaucoma (PACG)

• Aged ≥ 50 years, no gender restriction

• Case Group A: Undergoing glaucoma surgery with intraoperatively confirmed significant zonular laxity

• Case Group B: Undergoing glaucoma surgery with intraoperatively confirmed normal zonular morphology

• Control group: age- and sex-matched with case groups; clinically diagnosed with age-related cataract; normal anterior chamber depth and angle; no history or signs of glaucoma; undergoing cataract surgery

Locations
Other Locations
China
Zhongnan Hospital of Wuhan University
RECRUITING
Wuhan
Contact Information
Primary
Min Ke, doctor
Keminyk@163.com
18672395959
Backup
Xiaomin Chen, doctor
xminchen@whu.edu.cn
13657237773
Time Frame
Start Date: 2025-10-01
Estimated Completion Date: 2027-09-30
Participants
Target number of participants: 150
Treatments
Case Group A
PACG patients with zonular laxity
Case Group B
PACG patients without zonular laxity
Control Group
cataract patients without a history or signs of glaucoma
Related Therapeutic Areas
Sponsors
Leads: Zhongnan Hospital

This content was sourced from clinicaltrials.gov